American Journal of Cardiology
Volume 103, Issue 10 , Pages 1411-1416 , 15 May 2009

Relation of Adiponectin and High-Sensitivity C-Reactive Protein to Pulse-Wave Velocity and N-Terminal Pro-B-Type Natriuretic Peptide in the General Population

  • Shih-Hsien Sung, MD

      Affiliations

    • Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
    • ,
  • Shao-Yuan Chuang, PhD

      Affiliations

    • Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China
    • ,
  • Wayne Huey-Herng Sheu, MD, PhD

      Affiliations

    • Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China
    • ,
  • Wen-Jane Lee, PhD

      Affiliations

    • Department of Research and Education, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China
    • ,
  • Pesus Chou, DPH

      Affiliations

    • Department of Public Health, National Yang-Ming University, Taipei, Taiwan, Republic of China
    • Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan, Republic of China
    • ,
  • Chen-Huan Chen, MD

      Affiliations

    • Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
    • Department of Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
    • Department of Public Health, National Yang-Ming University, Taipei, Taiwan, Republic of China
    • Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan, Republic of China
    • Corresponding Author InformationCorresponding author: Tel: 866-2-2871-2121, ext. 2073; fax: 886-2-2871-7431

Received 10 November 2008 ,Revised 21 January 2009 ,Accepted 21 January 2009.

References 

  1. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51:1775–1783
  2. Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes Metab. 2007;9:246–258
  3. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 2002;324:1498–1502
  4. de Lemos JA, Hildebrandt P. Amino-terminal pro-B-type natriuretic peptides: testing in general populations. Am J Cardiol. 2008;101:16–20
  5. Chuang SY, Chen CH, Cheng CM, Chou P. Combined use of brachial-ankle pulse wave velocity and ankle-brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol. 2005;98:99–105
  6. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25:359–364
  7. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
  8. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–943
  9. Tartiere JM, Logeart D, Safar ME, Cohen-Solal A. Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure. J Hum Hypertens. 2006;20:213–219
  10. Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, et al Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation. 2007;115:3079–3085
  11. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–3390
  12. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. N-Terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension. 2005;46:660–666
  13. Sipila K, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, et al. Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism. 2007;56:320–326
  14. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol. 2006;47:72–75
  15. Ferreira I, Boreham CA, Twisk JW, Gallagher AM, Young IS, Murray LJ, et al. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project. J Hypertens. 2007;25:1009–1020
  16. Fukui M, Ose H, Kitagawa Y, Kamiuchi K, Nakayama I, Ohta M, et al. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with type 2 diabetes. Diabet Med. 2007;24:864–871
  17. Higashiura K, Ura N, Ohata J, Togashi N, Takagi S, Saitoh S, et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf). 2004;61:753–759
  18. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens. 2008;21:553–557
  19. Kojima S, Funahashi T, Maruyoshi H, Honda O, Sugiyama S, Kawano H, et al Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res. 2005;115:483–490
  20. Tomiyama H, Arai T, Koji Y, Yambe M, Hirayama Y, Yamamoto Y, et al. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis. 2004;174:373–377
  21. Haugen E, Furukawa Y, Isic A, Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol. 2008;125:216–219
  22. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem. 2006;52:853–859
  23. Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J. 2007;28:1162–1169
  24. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J. 2007;28:829–835
  25. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148–2159
  26. Kanda H, Kita Y, Okamura T, Kadowaki T, Yoshida Y, Nakamura Y, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?. J Hum Hypertens. 2005;19:165–172
  27. Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008;51:1377–1383
  28. Trippodo NC, Yamamoto J, Frolich ED. Whole-body venous capacity and effective total tissue compliance in SHR. Hypertension. 1981;3:104–112
  29. Keating GM, Goa KL. Nesiritide: a review of its use in acute decompensated heart failure. Drugs. 2003;63:47–70
  30. Yu WC, Chuang SY, Lin YP, Chen CH. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens. 2008;22:24–31

 This work was supported by serial Grants No. NSC 92-2320-B-010-058; NSC 93-2314-B-010-040; and NSC 94-2314-B-010-058 from the National Science Council; intramural Grant No.93-198C from the Taipei Veterans General Hospital; and Grants-in-Aid No. 91-02-032 and 93-02-014 from the Research Foundation of Cardiovascular Medicine, Taipei, Taiwan, Republic of China.

PII: S0002-9149(09)00475-5

doi: 10.1016/j.amjcard.2009.01.355

American Journal of Cardiology
Volume 103, Issue 10 , Pages 1411-1416 , 15 May 2009

Article Tools

* Image Usage & Resolution